External beam radiotherapy (EBRT) and high-dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: the impact of EBRT volume.

[1]  R. Schiappa,et al.  Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials. , 2018, Cancer treatment reviews.

[2]  R. Eeles,et al.  Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer , 2017, International journal of radiation oncology, biology, physics.

[3]  M. Levine,et al.  Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. , 2017, International Journal of Radiation Oncology, Biology, Physics.

[4]  C. Kay,et al.  Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose , 2017, PloS one.

[5]  D Baltas,et al.  High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[6]  W. J. Morris,et al.  Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cance , 2017, International journal of radiation oncology, biology, physics.

[7]  D. Pérol,et al.  Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study. , 2016, International journal of radiation oncology, biology, physics.

[8]  Jaw-Yuan Wang,et al.  A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma , 2016, Journal of radiation research.

[9]  C. Catton,et al.  Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis. , 2015, International journal of radiation oncology, biology, physics.

[10]  P. Hoskin,et al.  Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[11]  Y. Yamada,et al.  Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer , 2014, BJU international.

[12]  M. Parmar,et al.  Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. , 2014, The Lancet. Oncology.

[13]  S. van Dyk,et al.  Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer. , 2013, International journal of radiation oncology, biology, physics.

[14]  P. Hoskin,et al.  Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  M. Balducci,et al.  Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy. , 2011, International journal of radiation oncology, biology, physics.

[16]  R. Peschel,et al.  Whole pelvic radiotherapy versus prostate only radiotherapy in the management of locally advanced or aggressive prostate adenocarcinoma. , 2009, International journal of radiation oncology, biology, physics.

[17]  Y. Yamada,et al.  Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. , 2008, Brachytherapy.

[18]  Charles R. Thomas,et al.  An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. , 2007, International journal of radiation oncology, biology, physics.

[19]  A. Rockall,et al.  An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[20]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[21]  Joos V Lebesque,et al.  Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Qing Guo,et al.  Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Heidenreich,et al.  Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. , 2002, The Journal of urology.

[24]  G. Gustafson,et al.  Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  J. Michalski,et al.  Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate. , 1996, International journal of radiation oncology, biology, physics.

[26]  M. Zelefsky,et al.  Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. , 2017, European urology.

[27]  J. Millar,et al.  High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer. , 2010, Brachytherapy.

[28]  Lei Dong,et al.  Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. , 2008, International journal of radiation oncology, biology, physics.